{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T23:05:02Z","timestamp":1746227102737},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.steroids.2024.109425","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T16:56:03Z","timestamp":1713286563000},"page":"109425","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clomiphene citrate as a new modality in management of vaginal bleeding with depomedroxyprogesterone acetate (DMPA): A randomized controlled trial"],"prefix":"10.1016","volume":"206","author":[{"given":"Kareem","family":"Shaheen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hany H.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enas","family":"Mostafa Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Hashim Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sileem","family":"Ahmed Sileem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab","family":"Shehata Sayd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed E.","family":"ElHodiby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2024.109425_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2022.109100","article-title":"Variability and quantification of serum medroxyprogesterone acetate levels","volume":"187","author":"Bick","year":"2022","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2024.109425_b0010","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3109\/13625187.2014.936934","article-title":"Body composition and weight gain in new users of the three-monthly injectable contraceptive, depot-medroxyprogesterone acetate, after 12 months of follow-up","volume":"19","author":"dos Santos","year":"2014","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.steroids.2024.109425_b0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2004.06.011","article-title":"Contraceptive efficacy and safety of DMPA-SC","volume":"70","author":"Jain","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2024.109425_b0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jadohealth.2018.08.012","article-title":"Health care provider attitudes and practices related to \u2018quick start\u2019 provision of combined hormonal contraception and depot medroxyprogesterone acetate to adolescents","volume":"64","author":"Morgan","year":"2019","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.steroids.2024.109425_b0025","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00404-016-4192-9","article-title":"Binge eating and biochemical markers of appetite in new users of the contraceptive depot medroxyprogesterone acetate","volume":"294","author":"Silva dos Santos","year":"2016","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.steroids.2024.109425_b0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jadohealth.2012.04.007","article-title":"Depot medroxyprogesterone acetate use is not associated with risk of incident sexually transmitted infections among adolescent women","volume":"52","author":"Romer","year":"2013","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.steroids.2024.109425_b0035","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.contraception.2012.01.003","article-title":"Doxycycline in the treatment of bleeding with DMPA: A double-blinded randomized controlled trial","volume":"86","author":"Abdel-Aleem","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2024.109425_b0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/13625187.2019.1709963","article-title":"Depo-medroxyprogesterone acetate, weight gain and amenorrhea among obese adolescent and adult women","volume":"25","author":"Sims","year":"2020","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.steroids.2024.109425_b0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.contraception.2009.02.008","article-title":"Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: Systematic review and evidence-based comparisons","volume":"80","author":"Hubacher","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2024.109425_b0050","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0039-128X(03)00132-6","article-title":"Mifepristone for the prevention of breakthrough bleeding in new starters of depo-medroxyprogesterone acetate","volume":"68","author":"Jain","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2024.109425_b0055","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00404-018-4969-0","article-title":"Postpartum contraceptive counseling for first-time adolescent mothers: A randomized controlled trial","volume":"299","author":"Frarey","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.steroids.2024.109425_b0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.contraception.2007.03.006","article-title":"Chronic endometritis in DMPA users and Chlamydia trachomatis endometritis","volume":"76","author":"Thurman","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2024.109425_b0065","first-page":"43","article-title":"Unscheduled bleeding and contraceptive choice: increasing satisfaction and continuation rates","volume":"7","author":"Villavicencio","year":"2016","journal-title":"Open Access J. Contracept."},{"key":"10.1016\/j.steroids.2024.109425_b0070","unstructured":"A.M. Branum, J. Jones, Trends in long-acting reversible contraception use among U.S. women aged 15-44, NCHS Data Brief (2015) 1\u20138."},{"key":"10.1016\/j.steroids.2024.109425_b0075","first-page":"CD003449","article-title":"Treatment of vaginal bleeding irregularities induced by progestin only contraceptives","author":"Abdel-Aleem","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.steroids.2024.109425_b0080","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1507\/endocrj.K09E-368","article-title":"Clomiphene citrate elicits estrogen agonistic\/antagonistic effects differentially via estrogen receptors alpha and beta","volume":"57","author":"Kurosawa","year":"2010","journal-title":"Endocr. J."},{"key":"10.1016\/j.steroids.2024.109425_b0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.contraception.2006.08.012","article-title":"Recommendations for standardization of data collection and analysis of bleeding in combined hormone contraceptive trials","volume":"75","author":"Mishell","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2024.109425_b0090","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.contraception.2005.05.015","article-title":"Tamoxifen treatment of bleeding irregularities associated with Norplant use","volume":"72","author":"Abdel-Aleem","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2024.109425_b0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10456-005-9003-z","article-title":"Progestogen only contraception and endometrial break through bleeding","volume":"8","author":"Smith","year":"2005","journal-title":"Angiogenesis"},{"issue":"Suppl 2","key":"10.1016\/j.steroids.2024.109425_b0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/humrep\/11.suppl_2.45","article-title":"Endometrial vasculature in Norplant users","volume":"11","author":"Rogers","year":"1996","journal-title":"Hum. Reprod. Oxf. Engl."},{"key":"10.1016\/j.steroids.2024.109425_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2020.108735","article-title":"Medroxyprogesterone derivatives from microbial transformation as anti-proliferative agents and acetylcholineterase inhibitors (combined in vitro and in silico approaches)","volume":"164","author":"Yusop","year":"2020","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2024.109425_b0110","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2217\/WHE.10.36","article-title":"Estrogen-free oral hormonal contraception: Benefits of the progestin-only pill","volume":"6","author":"de Melo","year":"2010","journal-title":"Womens Health Lond. Engl."},{"issue":"Suppl 2","key":"10.1016\/j.steroids.2024.109425_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humrep\/11.suppl_2.1","volume":"11","author":"Said","year":"1996","journal-title":"Hum. Reprod. Oxf. Engl."},{"issue":"Suppl 3","key":"10.1016\/j.steroids.2024.109425_b0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/humrep\/15.suppl_3.30","article-title":"The role of selective oestrogen receptor modulators in the treatment of endometrial bleeding in women using long-acting progestin contraception","volume":"15","author":"Grow","year":"2000","journal-title":"Hum. Reprod. Oxf. Engl."},{"key":"10.1016\/j.steroids.2024.109425_b0125","doi-asserted-by":"crossref","first-page":"977","DOI":"10.5455\/2320-1770.ijrcog20141219","article-title":"Using phytoestrogens as aprophylaxis against irregular uterine bleeding possibly occurring while using Depot-medroxyprogesterone acetate (DMPA) as a contraceptive method","volume":"3","author":"Abd El Fattah","year":"2014","journal-title":"Int. J. Reprod. Contracept. Obstet. Gynecol."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X24000631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X24000631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T12:53:52Z","timestamp":1715172832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X24000631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":25,"alternative-id":["S0039128X24000631"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2024.109425","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clomiphene citrate as a new modality in management of vaginal bleeding with depomedroxyprogesterone acetate (DMPA): A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2024.109425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109425"}}